Timothy P. Walbert - 30 Sep 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Sep 2021
Net transactions value
-$5,515,140
Form type
4
Filing time
01 Oct 2021, 16:08:42 UTC
Previous filing
27 Aug 2021
Next filing
03 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -107,739 -13% $0.000000 739,984 17 Sep 2021 Direct
transaction HZNP Ordinary Shares Gift $0 +107,739 $0.000000 107,739 17 Sep 2021 See footnote F1
transaction HZNP Ordinary Shares Gift $0 -110,502 -15% $0.000000 629,482 17 Sep 2021 Direct
transaction HZNP Ordinary Shares Gift $0 +110,502 +526% $0.000000 131,496 17 Sep 2021 By Spouse
transaction HZNP Ordinary Shares Sale $3,349,382 -30,460 -4.8% $109.96 599,022 30 Sep 2021 Direct F2, F3
transaction HZNP Ordinary Shares Sale $2,098,552 -18,940 -3.2% $110.80 580,082 30 Sep 2021 Direct F2, F4
transaction HZNP Ordinary Shares Sale $67,206 -600 -0.1% $112.01 579,482 30 Sep 2021 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Timothy P. Walbert Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.48 to $110.47 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.48 to $111.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.73 to $112.12 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.